UPDATE 1-Bristol-Myers says shareholders vote to approve Celgene takeover
April 12, 2019 at 10:59 AM EDT
Bristol-Myers Squibb Co's shareholders voted to approve the drugmaker's $74 billion takeover of biotech Celgene Corp on Friday despite a campaign by activist hedge fund Starboard Value LP to scuttle the deal.
